China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Days Sales Outstanding : 54.78 (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is China Resources Double-Crane Pharmaceutical Co Days Sales Outstanding?

China Resources Double-Crane Pharmaceutical Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥1,702 Mil. China Resources Double-Crane Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥2,835 Mil. Hence, China Resources Double-Crane Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 54.78.

The historical rank and industry rank for China Resources Double-Crane Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SHSE:600062' s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.88 Med: 50.65 Max: 60.95
Current: 60.95

During the past 13 years, China Resources Double-Crane Pharmaceutical Co's highest Days Sales Outstanding was 60.95. The lowest was 43.88. And the median was 50.65.

SHSE:600062's Days Sales Outstanding is ranked better than
60.76% of 999 companies
in the Drug Manufacturers industry
Industry Median: 72.08 vs SHSE:600062: 60.95

China Resources Double-Crane Pharmaceutical Co's Days Sales Outstanding increased from Mar. 2023 (50.08) to Mar. 2024 (54.78).

China Resources Double-Crane Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for China Resources Double-Crane Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Double-Crane Pharmaceutical Co Days Sales Outstanding Chart

China Resources Double-Crane Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

43.88

50.97

48.45

48.85

51.86

China Resources Double-Crane Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															50.08	64.98	68.72	55.20	54.78

Competitive Comparison of China Resources Double-Crane Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Double-Crane Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Resources Double-Crane Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Resources Double-Crane Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where China Resources Double-Crane Pharmaceutical Co's Days Sales Outstanding falls into.

China Resources Double-Crane Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

China Resources Double-Crane Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1343.445	+	1561.264)	/	2 )	/	10222.132	*	365
=	1452.3545					/	10222.132	*	365
=	51.86

China Resources Double-Crane Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (1561.264	+	1843.267)	/	2 )	/	2835.466	*	365 / 4
=	1702.2655					/	2835.466	*	365 / 4
=	54.78

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

China Resources Double-Crane Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of China Resources Double-Crane Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

No. 1, East Second Road, Lijing, Wangjing, Chaoyang District, Beijing, CHN, 100102

Website

http://www.dcpc.com

China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Headlines

No Headlines